Allergan introduces REFRESH OPTIVE MEGA-3 enhanced with flaxseed oil
New offering restores lipid layer and brings hydration to all three layers of tear film damaged by Dry Eye.
Allergan has launched the over-the-counter (OTC) artificial tear REFRESH OPTIVE MEGA-3, the latest innovation in the REFRESH portfolio that fortifies the lipid layer when Meibomian Gland Dysfunction (MGD) patients suffer from Dry Eye. MEGA-3 is formulated with flaxseed and castor oil, two natural, plant-based oils which protect tears from evaporating while nourishing the lipid layer damaged by Dry Eye and providing essential hydration to all three layers of the tear film. It's clinically proven to treat the signs and symptoms of Dry Eye.
"I recommend MEGA-3 for patients suffering from Dry Eye symptoms associated with MGD, who are looking for relief. In addition, MEGA-3 is specially formulated for stability, so no shaking is required -- just drop and go." said Milton M. Hom, OD, FAAO.
An estimated 25 million people in the US suffer from Dry Eye symptoms, including irritation, blurred vision, sensitivity to light, burning, stinging, dryness and excessive tearing. MEGA-3 also contains carboxymethylcellulose (CMC), an active lubricant found in all REFRESH OPTIVE formulas. This water-loving polymer, binds to epithelial cells to maintain moisture on the ocular surface for rapid on-eye comfort and long-lasting relief."As the innovators of the number one doctor-recommended brand of artificial tears1, we are pleased to expand our robust dry eye portfolio with REFRESH OPTIVE MEGA-3," said Herm Cukier, Senior Vice President, Eye Care. "Our REFRESH line of patented products offer patients a wide variety of options to treat their individual dry eye needs."
All OPTIVE products include the patented osmoprotectant formula that includes three compatible solutes -- glycerin, I-carnitine and erythritol -- all of which deliver added protection to the corneal epithelial cells against hypertonic stress. REFRESH OPTIVE MEGA-3 contains a fourth osmoprotectant, trehalose, for an advanced approach to treating Dry Eye symptoms.
MEGA-3 is available in 30-count single-use vials and can be found nationwide at various retail locations where OTC eye drops are sold.
Related News
-
News Eli Lilly gets ready to launch five new drugs in 2023
Eli Lilly, the American pharmaceutical company (IN, USA) are gearing up for a big year ahead, with hopes to launch five new drugs and capitalise on growing obesity and Alzheimer’s disease markets. -
News Amgen buys Horizon for $27.8 billion in bold step into the rare disease market
Amgen Inc buys pharmaceutical company Horizon Therapeutics in a multibillion-dollar deal, in hopes to capitalise on it's portfolio of drugs in the highly sort after rare disease market. -
News Pharma Supply Chain People Moves
The latest appointments and promotions across the pharmaceutical supply chain. -
News Merck to donate new Ebola vaccine to defend against outbreaks in Uganda
Pharmaceutical giant Merck has announced they will be speeding up the processing of a new vaccine against the latest strain of the Ebola virus, to be donated to a global non-profit organisation for distribution -
News CPHI Podcast Series: Driving innovation with pharmaceutical startups
The latest episode in the CPHI Podcast Series explores how startups are driving innovation by taking high-risk approaches and doing business with greater agility. -
News Greener and efficient processes: Quaternary Ammonium Salts
Quaternary Ammonium Salts play a crucial part in Organic Chemistry processes at many major industries. Discover why.
-
News Biosimilars save patients $11B annually, but barriers to adoption remain in US market
Biosimilars introduce competition into the biologics market, driving down prices and increasing patient access. -
News WHO recommends use of two monoclonal antibody treatments against Ebola
The health body recommended use of treatments by Regeneron and Ridgeback Bio
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance